Dokuz Eylul University School of Medicine
Izmir, 35000, Turkey (Türkiye)
NCT Number: NCT06903650
This study aimed to evaluate the effect of salpingectomy operation on ovarian reserve. Ovarian reserve was evaluated by measuring anti-mullerian hormone levels from serum samples taken from the patients before the operation and 6 weeks after the operation. Ovarian doppler flow were evaluated by measuring the ovarian artery pulsatility index with transvaginal ultrasonography preoperatively, postoperative days 2 and postoperative weeks 6 . In our study, it was determined that ovarian functions may be negatively affected in the acute period after salpingectomy operation.
Looking for future studies?
Notify Me37 year–45 year
Female
Observational
Izmir, 35000, Turkey (Türkiye)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The effect of salpingectomy operation on ovarian reserve
Time frame: perioperative, postoperative days 2 , postoperative weeks 6
rate of 0,87/ 0,84/ 0,76
Time frame: perioperative, postoperative days 2, postoperative weeks 6
rate of 0,89/ 0,79/ 0.80
Time frame: perioperative-postoperative weeks 6
Concentration of 1 ng/mL / 0,79 ng/mL
Dokuz Eylul University
Other
Evaluation of the Effect of Salpingectomy Operation on Ovarian Reserve With Anti-Mullerian Hormone and Ovarian Doppler Ultrasonography
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01329302
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Schiltigheim, France
View Trial DetailsNCT06290895
Genital Diseases, Infertility
Montreal, Quebec, Canada
View Trial DetailsNCT01197456
Breast Cancer, Breast Diseases
La Jolla, California, United States
View Trial DetailsNCT01577472
Female Infertility, Female Urogenital Diseases
Basel, Switzerland
View Trial Details